Prediction of prognosis of immune checkpoint inhibitors combined with anti-angiogenic agents for unresectable hepatocellular carcinoma by machine learning-based radiomics

Abstract Objectives This study aims to develop and validate a novel radiomics model utilizing magnetic resonance imaging (MRI) to predict progression-free survival (PFS) in patients with unresectable hepatocellular carcinoma (uHCC) who are receiving a combination of immune checkpoint inhibitors (ICI...

Полное описание

Библиографические подробности

Главные авторы:	Xuni Xu, Xue Jiang, Haoran Jiang, Xiaoye Yuan, Mengjing Zhao, Yuqi Wang, Gang Chen, Gang Li, Yuxia Duan
Формат:	Artigo
Язык:	Inglês
Опубликовано:	BMC 2025-05-01
Серии:	BMC Cancer
Предметы:	Hepatocellular carcinoma Radiomics Progression‑free survival Immune checkpoint inhibitors Anti-angiogenic agents
Online-ссылка:	https://doi.org/10.1186/s12885-025-14247-0
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!